Overcoming nonviral gene delivery barriers: perspective and future
- PMID: 24093932
- PMCID: PMC5232591
- DOI: 10.1021/mp400467x
Overcoming nonviral gene delivery barriers: perspective and future
Abstract
A key end goal of gene delivery research is to develop clinically relevant vectors that can be used to combat elusive diseases such as AIDS. Despite promising engineering strategies, efficiency and ultimately gene modulation efficacy of nonviral vectors have been hindered by numerous in vitro and in vivo barriers that have resulted in subviral performance. In this perspective, we concentrate on the gene delivery barriers associated with the two most common classes of nonviral vectors, cationic-based lipids and polymers. We present the existing delivery barriers and summarize current vector-specific strategies to overcome said barriers.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
References
-
- Friedmann T, Roblin R. Gene therapy for human genetic disease? Science. 1972;175(4025):949–55. - PubMed
-
- Elsabahy M, Nazarali A, Foldvari M. Non-viral nucleic acid delivery: key challenges and future directions. Current drug delivery. 2011;8(3):235–44. - PubMed
-
- Vannucci L, Lai M, Chiuppesi F, Ceccherini-Nelli L, Pistello M. Viral vectors: a look back and ahead on gene transfer technology. The new microbiologica. 2013;36(1):1–22. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
